HEADER HYDROLASE/INHIBITOR 19-NOV-24 9EEI TITLE CRYSTAL STRUCTURE OF THE SARS-COV-2 OMICRON NSP5 MAIN PROTEASE (MPRO) TITLE 2 E166V MUTANT IN COMPLEX WITH INHIBITOR GC376 COMPND MOL_ID: 1; COMPND 2 MOLECULE: 3C-LIKE PROTEINASE NSP5; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 3264-3569; COMPND 5 SYNONYM: 3CL-PRO,3CLP,MAIN PROTEASE,MPRO,NON-STRUCTURAL PROTEIN 5, COMPND 6 NSP5,SARS CORONAVIRUS MAIN PROTEINASE; COMPND 7 EC: 3.4.22.69; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 3 2; SOURCE 4 ORGANISM_TAXID: 2697049; SOURCE 5 VARIANT: OMICRON; SOURCE 6 GENE: REP, 1A-1B; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 9 EXPRESSION_SYSTEM_VARIANT: RIL KEYWDS VIRAL PROTEIN, NSP5, SARS-COV-2, GC376, DRUG RESISTANCE, HYDROLASE- KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR G.NEILSEN,K.A.KIRBY,S.G.SARAFIANOS REVDAT 1 18-JUN-25 9EEI 0 JRNL AUTH G.NEILSEN,S.LAN,R.L.SLACK,Z.C.LORSON,A.EMANUELLI CASTANER, JRNL AUTH 2 R.LEE,K.G.EDWARDS,H.ZHANG,J.LEE,W.A.CANTARA,M.E.CILENTO, JRNL AUTH 3 H.ZHANG,R.DE,F.AMBLARD,P.R.TEDBURY,K.A.KIRBY,R.F.SCHINAZI, JRNL AUTH 4 S.G.SARAFIANOS JRNL TITL STRATEGY TO OVERCOME A NIRMATRELVIR RESISTANCE MECHANISM IN JRNL TITL 2 THE SARS-COV-2 NSP5 PROTEASE. JRNL REF SCI ADV V. 11 V8875 2025 JRNL REFN ESSN 2375-2548 JRNL PMID 40479048 JRNL DOI 10.1126/SCIADV.ADV8875 REMARK 2 REMARK 2 RESOLUTION. 2.76 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.20.1_4487: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.76 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.58 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.0 REMARK 3 NUMBER OF REFLECTIONS : 6919 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.206 REMARK 3 R VALUE (WORKING SET) : 0.204 REMARK 3 FREE R VALUE : 0.258 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.650 REMARK 3 FREE R VALUE TEST SET COUNT : 322 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 48.5800 - 3.4800 0.97 3315 161 0.1876 0.2280 REMARK 3 2 3.4800 - 2.7600 0.97 3282 161 0.2543 0.3507 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.390 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 32.150 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.004 2450 REMARK 3 ANGLE : 0.840 3327 REMARK 3 CHIRALITY : 0.054 374 REMARK 3 PLANARITY : 0.006 430 REMARK 3 DIHEDRAL : 13.604 867 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 9EEI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-NOV-24. REMARK 100 THE DEPOSITION ID IS D_1000287645. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-APR-23 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS JAN 10, 2022 REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.7.9 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 6954 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.750 REMARK 200 RESOLUTION RANGE LOW (A) : 56.430 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.0 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : 0.09600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.75 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.90 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : 3.20 REMARK 200 R MERGE FOR SHELL (I) : 0.84500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.8.3 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.89 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.04 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG3350, SODIUM FORMATE, PH 6.5, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z+1/2 REMARK 290 4555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 11.90048 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 26.91150 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 56.43015 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 11.90048 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 26.91150 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 56.43015 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2980 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 25280 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -19.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 45.51400 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLN A 306 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 33 -123.65 54.22 REMARK 500 ASN A 84 -116.62 56.89 REMARK 500 LEU A 141 -168.17 -112.74 REMARK 500 TYR A 154 -92.52 59.18 REMARK 500 HIS A 164 -53.35 -139.10 REMARK 500 ARG A 222 50.15 -109.07 REMARK 500 REMARK 500 REMARK: NULL REMARK 630 REMARK 630 MOLECULE TYPE: PEPTIDE-LIKE INHIBITOR REMARK 630 MOLECULE NAME: N~2~-[(BENZYLOXY)CARBONYL]-N-{(2S)-1-HYDROXY-3-[(3S) REMARK 630 -2-OXOPYRROLIDIN-3-YL]PROPAN-2-YL}-L-LEUCINAMIDE REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 UED A 401 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: NULL REMARK 630 DETAILS: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 8TXI RELATED DB: PDB REMARK 900 WA1 E166V SARS-COV-2 NSP5 PROTEIN IN COMPLEX WITH GC376 DBREF 9EEI A 1 306 UNP P0DTD1 R1AB_SARS2 3264 3569 SEQADV 9EEI HIS A 132 UNP P0DTD1 PRO 3395 ENGINEERED MUTATION SEQADV 9EEI VAL A 166 UNP P0DTD1 GLU 3429 ENGINEERED MUTATION SEQRES 1 A 306 SER GLY PHE ARG LYS MET ALA PHE PRO SER GLY LYS VAL SEQRES 2 A 306 GLU GLY CYS MET VAL GLN VAL THR CYS GLY THR THR THR SEQRES 3 A 306 LEU ASN GLY LEU TRP LEU ASP ASP VAL VAL TYR CYS PRO SEQRES 4 A 306 ARG HIS VAL ILE CYS THR SER GLU ASP MET LEU ASN PRO SEQRES 5 A 306 ASN TYR GLU ASP LEU LEU ILE ARG LYS SER ASN HIS ASN SEQRES 6 A 306 PHE LEU VAL GLN ALA GLY ASN VAL GLN LEU ARG VAL ILE SEQRES 7 A 306 GLY HIS SER MET GLN ASN CYS VAL LEU LYS LEU LYS VAL SEQRES 8 A 306 ASP THR ALA ASN PRO LYS THR PRO LYS TYR LYS PHE VAL SEQRES 9 A 306 ARG ILE GLN PRO GLY GLN THR PHE SER VAL LEU ALA CYS SEQRES 10 A 306 TYR ASN GLY SER PRO SER GLY VAL TYR GLN CYS ALA MET SEQRES 11 A 306 ARG HIS ASN PHE THR ILE LYS GLY SER PHE LEU ASN GLY SEQRES 12 A 306 SER CYS GLY SER VAL GLY PHE ASN ILE ASP TYR ASP CYS SEQRES 13 A 306 VAL SER PHE CYS TYR MET HIS HIS MET VAL LEU PRO THR SEQRES 14 A 306 GLY VAL HIS ALA GLY THR ASP LEU GLU GLY ASN PHE TYR SEQRES 15 A 306 GLY PRO PHE VAL ASP ARG GLN THR ALA GLN ALA ALA GLY SEQRES 16 A 306 THR ASP THR THR ILE THR VAL ASN VAL LEU ALA TRP LEU SEQRES 17 A 306 TYR ALA ALA VAL ILE ASN GLY ASP ARG TRP PHE LEU ASN SEQRES 18 A 306 ARG PHE THR THR THR LEU ASN ASP PHE ASN LEU VAL ALA SEQRES 19 A 306 MET LYS TYR ASN TYR GLU PRO LEU THR GLN ASP HIS VAL SEQRES 20 A 306 ASP ILE LEU GLY PRO LEU SER ALA GLN THR GLY ILE ALA SEQRES 21 A 306 VAL LEU ASP MET CYS ALA SER LEU LYS GLU LEU LEU GLN SEQRES 22 A 306 ASN GLY MET ASN GLY ARG THR ILE LEU GLY SER ALA LEU SEQRES 23 A 306 LEU GLU ASP GLU PHE THR PRO PHE ASP VAL VAL ARG GLN SEQRES 24 A 306 CYS SER GLY VAL THR PHE GLN HET UED A 401 36 HETNAM UED N~2~-[(BENZYLOXY)CARBONYL]-N-{(2S)-1-HYDROXY-3-[(3S)-2- HETNAM 2 UED OXOPYRROLIDIN-3-YL]PROPAN-2-YL}-L-LEUCINAMIDE HETSYN UED GC373 BOUND FORM, GC376 BOUND FORM FORMUL 2 UED C21 H31 N3 O5 HELIX 1 AA1 SER A 10 GLY A 15 1 6 HELIX 2 AA2 HIS A 41 CYS A 44 5 4 HELIX 3 AA3 GLU A 47 ASN A 51 5 5 HELIX 4 AA4 ASN A 53 ARG A 60 1 8 HELIX 5 AA5 SER A 62 PHE A 66 5 5 HELIX 6 AA6 ILE A 200 GLY A 215 1 16 HELIX 7 AA7 THR A 226 TYR A 237 1 12 HELIX 8 AA8 THR A 243 LEU A 250 1 8 HELIX 9 AA9 LEU A 250 GLY A 258 1 9 HELIX 10 AB1 ALA A 260 GLY A 275 1 16 HELIX 11 AB2 THR A 292 GLY A 302 1 11 SHEET 1 AA1 7 VAL A 73 LEU A 75 0 SHEET 2 AA1 7 LEU A 67 ALA A 70 -1 N ALA A 70 O VAL A 73 SHEET 3 AA1 7 MET A 17 CYS A 22 -1 N THR A 21 O LEU A 67 SHEET 4 AA1 7 THR A 25 LEU A 32 -1 O LEU A 27 N VAL A 20 SHEET 5 AA1 7 VAL A 35 PRO A 39 -1 O TYR A 37 N LEU A 30 SHEET 6 AA1 7 VAL A 86 VAL A 91 -1 O LEU A 87 N CYS A 38 SHEET 7 AA1 7 VAL A 77 GLY A 79 -1 N ILE A 78 O LYS A 90 SHEET 1 AA2 7 VAL A 73 LEU A 75 0 SHEET 2 AA2 7 LEU A 67 ALA A 70 -1 N ALA A 70 O VAL A 73 SHEET 3 AA2 7 MET A 17 CYS A 22 -1 N THR A 21 O LEU A 67 SHEET 4 AA2 7 THR A 25 LEU A 32 -1 O LEU A 27 N VAL A 20 SHEET 5 AA2 7 VAL A 35 PRO A 39 -1 O TYR A 37 N LEU A 30 SHEET 6 AA2 7 VAL A 86 VAL A 91 -1 O LEU A 87 N CYS A 38 SHEET 7 AA2 7 MET A 82 GLN A 83 -1 N GLN A 83 O VAL A 86 SHEET 1 AA3 5 LYS A 100 PHE A 103 0 SHEET 2 AA3 5 CYS A 156 VAL A 166 1 O VAL A 157 N LYS A 100 SHEET 3 AA3 5 VAL A 148 ASP A 153 -1 N ASN A 151 O SER A 158 SHEET 4 AA3 5 THR A 111 TYR A 118 -1 N SER A 113 O PHE A 150 SHEET 5 AA3 5 SER A 121 ALA A 129 -1 O SER A 123 N ALA A 116 SHEET 1 AA4 3 LYS A 100 PHE A 103 0 SHEET 2 AA4 3 CYS A 156 VAL A 166 1 O VAL A 157 N LYS A 100 SHEET 3 AA4 3 HIS A 172 THR A 175 -1 O ALA A 173 N MET A 165 LINK SG CYS A 145 C21 UED A 401 1555 1555 1.77 CRYST1 45.514 53.823 114.930 90.00 100.89 90.00 I 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021971 0.000000 0.004227 0.00000 SCALE2 0.000000 0.018579 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008861 0.00000 TER 2360 PHE A 305 HETATM 2361 C7 AUED A 401 44.478 -25.028 -14.493 0.49 70.08 C HETATM 2362 C7 BUED A 401 42.634 -23.212 -14.193 0.51 65.40 C HETATM 2363 O8 UED A 401 43.118 -24.538 -14.500 1.00 70.46 O HETATM 2364 C9 UED A 401 42.163 -25.455 -14.741 1.00 75.52 C HETATM 2365 O10 UED A 401 41.020 -25.394 -14.349 1.00 81.55 O HETATM 2366 C1 AUED A 401 44.851 -25.394 -13.059 0.49 69.76 C HETATM 2367 C1 BUED A 401 42.906 -22.270 -15.360 0.51 64.35 C HETATM 2368 C2 AUED A 401 44.088 -24.929 -11.998 0.49 69.59 C HETATM 2369 C2 BUED A 401 43.174 -22.775 -16.620 0.51 59.90 C HETATM 2370 C3 AUED A 401 44.436 -25.267 -10.700 0.49 70.33 C HETATM 2371 C3 BUED A 401 43.419 -21.905 -17.671 0.51 61.67 C HETATM 2372 C4 AUED A 401 45.541 -26.068 -10.466 0.49 65.53 C HETATM 2373 C4 BUED A 401 43.390 -20.537 -17.457 0.51 62.29 C HETATM 2374 C5 AUED A 401 46.300 -26.532 -11.528 0.49 63.08 C HETATM 2375 C5 BUED A 401 43.119 -20.036 -16.196 0.51 57.05 C HETATM 2376 C6 AUED A 401 45.954 -26.195 -12.824 0.49 67.78 C HETATM 2377 C6 BUED A 401 42.875 -20.904 -15.146 0.51 63.29 C HETATM 2378 N11 UED A 401 42.623 -26.478 -15.473 1.00 65.96 N HETATM 2379 C12 UED A 401 41.945 -27.763 -15.446 1.00 67.08 C HETATM 2380 C17 UED A 401 41.867 -28.302 -14.011 1.00 73.52 C HETATM 2381 O18 UED A 401 42.878 -28.311 -13.308 1.00 75.48 O HETATM 2382 C13 UED A 401 42.677 -28.728 -16.380 1.00 59.42 C HETATM 2383 C14 UED A 401 42.519 -28.440 -17.875 1.00 64.57 C HETATM 2384 C15 UED A 401 41.040 -28.496 -18.253 1.00 76.19 C HETATM 2385 C16 UED A 401 43.280 -29.476 -18.704 1.00 81.65 C HETATM 2386 N19 UED A 401 40.703 -28.747 -13.526 1.00 75.13 N HETATM 2387 C20 UED A 401 40.591 -29.268 -12.173 1.00 69.24 C HETATM 2388 C21 UED A 401 40.230 -30.744 -12.268 1.00 76.21 C HETATM 2389 O22 UED A 401 40.493 -31.364 -11.045 1.00 75.41 O HETATM 2390 C24 UED A 401 39.568 -28.488 -11.348 1.00 72.35 C HETATM 2391 C25 UED A 401 40.087 -27.050 -11.191 1.00 75.43 C HETATM 2392 C26 UED A 401 41.302 -26.869 -10.270 1.00 72.51 C HETATM 2393 C27 UED A 401 41.023 -25.593 -9.483 1.00 61.27 C HETATM 2394 N28 UED A 401 39.601 -25.355 -9.687 1.00 77.75 N HETATM 2395 C29 UED A 401 39.026 -26.124 -10.614 1.00 78.96 C HETATM 2396 O30 UED A 401 37.842 -26.096 -10.957 1.00 74.91 O CONECT 1123 2388 CONECT 2361 2363 2366 CONECT 2362 2363 2367 CONECT 2363 2361 2362 2364 CONECT 2364 2363 2365 2378 CONECT 2365 2364 CONECT 2366 2361 2368 2376 CONECT 2367 2362 2369 2377 CONECT 2368 2366 2370 CONECT 2369 2367 2371 CONECT 2370 2368 2372 CONECT 2371 2369 2373 CONECT 2372 2370 2374 CONECT 2373 2371 2375 CONECT 2374 2372 2376 CONECT 2375 2373 2377 CONECT 2376 2366 2374 CONECT 2377 2367 2375 CONECT 2378 2364 2379 CONECT 2379 2378 2380 2382 CONECT 2380 2379 2381 2386 CONECT 2381 2380 CONECT 2382 2379 2383 CONECT 2383 2382 2384 2385 CONECT 2384 2383 CONECT 2385 2383 CONECT 2386 2380 2387 CONECT 2387 2386 2388 2390 CONECT 2388 1123 2387 2389 CONECT 2389 2388 CONECT 2390 2387 2391 CONECT 2391 2390 2392 2395 CONECT 2392 2391 2393 CONECT 2393 2392 2394 CONECT 2394 2393 2395 CONECT 2395 2391 2394 2396 CONECT 2396 2395 MASTER 244 0 1 11 22 0 0 6 2388 1 37 24 END